What this means
This study will check if a supplement called Youniqor is safe to take daily for eight weeks. It is still recruiting, and no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60–80
- Where
- 1 site
The science
- Registered title
- Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults
- Trial ID
- NCT07442097 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Aging, Healthy
- What is tested
- Youniqor
- Sponsor
- YOXLO B.V.
- Ages
- 60 Years to 80 Years
- Dates
- First posted Mar 2, 2026 · updated Mar 2, 2026
Registry summary
The goal of this clinical trial is to evaluate the safety and tolerability of the nutritional supplement Youniqor in healthy older adults. The main questions it aims to answer are:
Is Youniqor safe and well tolerated when taken daily by healthy adults aged 60 to 80 years? Are there any adverse events or clinically relevant changes in vital signs or laboratory parameters during the study period?
Participants will:
Take Youniqor daily for 8 weeks Attend scheduled study visits for safety assessments, including vital signs, blood and urine tests, and electrocardiograms Report any adverse events during the study period
Sites (1)
- Vedic Lifesciences Pvt. Ltd., Pune, Maharashtra, India